Does RIBOCICLIB Cause Deep vein thrombosis? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Deep vein thrombosis have been filed in association with RIBOCICLIB (KISQALI). This represents 0.4% of all adverse event reports for RIBOCICLIB.
102
Reports of Deep vein thrombosis with RIBOCICLIB
0.4%
of all RIBOCICLIB reports
15
Deaths
47
Hospitalizations
How Dangerous Is Deep vein thrombosis From RIBOCICLIB?
Of the 102 reports, 15 (14.7%) resulted in death, 47 (46.1%) required hospitalization, and 14 (13.7%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which RIBOCICLIB Alternatives Have Lower Deep vein thrombosis Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN